| Literature DB >> 35631482 |
Lingping Zhang1, Marie Wahlgren1, Björn Bergenståhl1.
Abstract
Oil-based drug delivery systems have been studied in different aspects. The present study proposes a new application for an oil-based delivery system, focusing on controlled release until the drug reaches the later part of the small intestine. Bulk surfactants and interfacial surfactants were added into the oil formulation to provide a better mechanistic understating of the lipolysis. Validation of the modified in vitro method shows the overall conversion from medium-chain triglyceride oil (MCT oil) to free fatty acids (FFA) of 100 ± 4% in five replicates. This fully converted level and high reproducibility are fundamental for the following investigations where any retarding effect can be distinguished from the experimental errors. The results show that viscosity and thermodynamic activity have limited retardation. Furthermore, the former may change the kinetics of lipolysis, while the latter changes the equilibrium level. The gel-forming retarder (ethylcellulose) displayed a strong effect. Whereas the lipolysis was significantly retarded (>50%) when the retarders altered the interfacial composition (poloxamer 407), degradable interfacial surfactants did not have the same effect. However, surface-active, lipolysis-resistant retarders with a high CMC did not show a retarding effect.Entities:
Keywords: in vitro method; later part of the small gastrointestinal tract; oil-based delivery system
Year: 2022 PMID: 35631482 PMCID: PMC9144740 DOI: 10.3390/pharmaceutics14050896
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
The initial compositions of the simulated intestinal fluids.
| Name | Reference Concentration * | Concentration after Modification |
|---|---|---|
| Bile extract | 1.5–6.6 mmol/L | 8 mmol/L |
| Phosphatidylcholine (soybean origin) | 0 | 2 mmol/L |
| NaCl | 150 mmol/L | 150 mmol/L |
| Ca2+ | 4–12 mmol/L | 15 mmol/L |
| Trizma-maleate | 2 mmol/L | 2 mmol/L |
| Pancreatin | 270–1340 USP Unit | 675 TBU |
| Total volume | 300 mL | 100 mL |
* Data from [34].
Molecular mass and critical micelle concentration (CMC) of interfacial retarders monooleate, polysorbate 80, poloxamer 407, and cetearyl glucoside.
| Interfacial Retarders | Molecular Mass | CMC * |
|---|---|---|
| Monooleate | 356 | 1.4 |
| Polysorbate 80 | 1310 | 1.6 |
| Poloxamer 407 | 12,600 | 35 |
| C12E5 | 406 | 28 |
| Cetearyl glucoside | 404 | 0.40 |
* The CMC values of monooleate, polysorbate 80, poloxamer 407, and C12E5 are recalculated from [46,47,48,49]. The CMC value of cetearyl glucoside is given by the manufacturer.
The viscosities of different formulations after pre-emulsification: dimethicon 25 cSt 16% and 32%, dimethicon 750 cSt 16% and 32%, PGPR 16% and 32%, ethylcellulose 300 cP, 10%.
| Retarders | MCT Oil | Dimethicon | Dimethicon | Dimethicon 750 cSt, 16% | Dimethicon 750 cSt, 32% | PGPR, | PGPR, | Ethylcellulose |
|---|---|---|---|---|---|---|---|---|
| Viscosity (mPa·s−1) | 16 | 13 | 14 | 26 | 49–34 | 36 | 80 | Too high to measure |
| Viscosity ratios to MCT oil | 1 | 0.81 | 0.87 | 1.6 | 3.0–2.1 * | 2.25 | 5 | |
| Conversion (2 h) ( | 100% | 98% | 91% | 92% | 89% | 98% | 98% | 38% |
| t50% (min) | 3.4 | 3.4 | 3.8 | 3.4 | 13.8 | 1.8 | 2.0 | >120 min |
* Retarders except for dimethicon 750 cSt show Newtonian character within the shear rate range of 10–100 s−1. Dimethicon 750 cSt is shear thinning. ** Standard error of mean of conversion data set (including bulk retarders and interfacial retarders) is 2%.
Figure 1Relative conversion of MCT oil in the presence of different bulk retarders: PGPR 32%, dimethicon 750 cSt 32%, ethylcellulose 300 cP 32%. The curve is a mean value of duplicate measurements. The relative standard error of the method is 1.2%.
Thermodynamic activity, final conversion (2 h), and the time point when reaching half final conversion (t50%) of hexadecane 16% and 32%, and dimethicon 25 cSt 32%.
| Retarders | Hexadecane 16% | Hexadecane 32% | Dimethicon 25 cSt, 32% |
|---|---|---|---|
| Thermodynamic activity | 0.73 | 0.58 | N.A. |
| Viscosity ratio to MCT oil | 0.69 | 0.48 | 0.87 |
| Conversion (2 h) ( | 83% | 83% | 92% |
| t50% (min) | 2.7 | 4.4 | 3.8 |
N.A. None applicable for dimethicon to usethe same thermodynamic activity estimation suggested for hexadecane. Standard error of mean of conversion data set (including bulk retarders and interfacial retarders) is 2%.
Figure 2The relative conversion curve of hexadecane 16% and 32% and pure oil.
Figure 3(a) Conversion of digestible interfacial retarders: monooleate 3%, and polysorbate, 3% and 6%, respectively. (b) Conversion of undigestible interfacial retarders: poloxamer 407 3% and 6%. (c) Conversion of undigestible interfacial retarders: cetearylglucoside 6%, C12E5 3% and 6%.
Interfacial tension after the stability and conversion: monooleate, polysorbate 80, poloxamer 407, and cetearyl glucoside.
| Retarders | Monooleate 3% | Monooleate 6% | Polysorbate 80, 3% | Polysorbate 80, 6% | Poloxamer 407, 3% | Poloxamer 407, 6% | C12E5 | C12E5 | Cetearyl Glucoside 6% |
|---|---|---|---|---|---|---|---|---|---|
| Interfacial tension after | N.A. | N.A. | 4 | 4 | 6 | 6 | <2 | <2 | N.A. |
| Conversion (2 h) ( | 100% | 92% | 93% | 93% | 81% | 23% | 91% | 90% | 98% |
| t50% (min) | 3.1 | 6.0 | 12.6 | 14.5 | 5.4 | >120 min | 10 | 8.1 | 3.5 |
N.A. Nonapplicable. Monooleate and cetearylglucoside precipitated in the syringe. * The surface tension of C12E5 is lower than the detection limit; therefore, we assume it is less than 2 mN·m−1. Standard error of mean of conversion data set (including bulk retarders and interfacial retarders) is 2%.